Gallacher Capital Management LLC Catalyst Pharmaceuticals, Inc. Transaction History

Gallacher Capital Management LLC

  • $218 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024
BUY
$14.68 - $16.92 $272,519 - $314,102
18,564 New
18,564 $288 Million
Q4 2023

Feb 06, 2024
SELL
$11.78 - $17.29 $36,235 - $53,184
-3,076 Reduced 17.44%
14,561 $245 Million
Q3 2023

Nov 13, 2023
BUY
$11.69 - $15.02 $206,176 - $264,907
17,637 New
17,637 $206 Million

Others Institutions Holding CPRX

# of Institutions
326
Shares Held
94.6M
Call Options Held
19.1K
Put Options Held
51.1K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.12B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Gallacher Capital Management LLC Portfolio

Follow Gallacher Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gallacher Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gallacher Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email